| Drug Name |
Valganciclovir hydrochloride |
| Drug ID |
BADD_D02327 |
| Description |
Valganciclovir hydrochloride (Valcyte, manufactured by Roche) is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases. |
| Indications and Usage |
Valganciclovir is an antiviral medication used for the treatment of cytomegalovirus infections. |
| Marketing Status |
Prescription |
| ATC Code |
J05AB14 |
| DrugBank ID |
DB01610
|
| KEGG ID |
D03256
|
| MeSH ID |
D000077562
|
| PubChem ID |
135413534
|
| TTD Drug ID |
D06GWF
|
| NDC Product Code |
63629-2288; 0603-6330; 69875-8044; 17337-0040; 61876-0072; 0004-0039; 65862-756; 42291-875; 63285-852; 65862-753; 65015-818; 65977-0070; 27241-159; 43598-356; 71666-008; 12869-038; 63739-357; 65015-798; 0591-2579; 55111-929; 55111-884; 38779-3065 |
| Synonyms |
Valganciclovir | Ganciclovir L-valyl Ester | Ganciclovir L valyl Ester | Valcyt | Valganciclovir Hydrochloride | Valcyte |
